Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.
Song D, Wu Y, Li J, Liu J, Yi Z, Wang X, Sun J, Li L, Wu Q, Chen Y, Fang H, Luan T, Du H, Huang J, Peng W, Wei Y, Li F, Li Q, Zhang L, Zhu Y, Wan J, Ren G, Li H.
Song D, et al. Among authors: wu y.
J Clin Invest. 2024 Nov 15;134(22):e183366. doi: 10.1172/JCI183366.
J Clin Invest. 2024.
PMID: 39545420